Bioequivalence of a newly developed 17β-estradiol tablet versus an identical reference formulation

Arzneimittel-Forschung/Drug Research

Volumn 50, Issue 10, 2000, Pages 910-914

  Gisclon, L G ^a   Bowen, A J ^a   O'Reilly, T E ^a   Lakewold, D ^a   Curtin, C R ^a   Larson, K L ^a   Palmer, S A ^a   Natarajan, J ^a   Wong, F A ^a  

^a NONE   (United States)

Author keywords

17 Estradiol, micronized tablets; CAS 50 28 2; Estrogen replacement therapy; Prefest(TM), bioequivalence

Indexed keywords

ESTRADIOL; ESTRONE; ESTRONE SULFATE; FOLLITROPIN; PREFEST;

ABDOMINAL PAIN; ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BACKACHE; BIOEQUIVALENCE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG ELIMINATION; DRUG FORMULATION; DRUG HALF LIFE; DRUG SAFETY; DRUG TOLERABILITY; ESTRADIOL BLOOD LEVEL; ESTROGEN THERAPY; ESTRONE BLOOD LEVEL; FEMALE; HEADACHE; HUMAN; HUMAN EXPERIMENT; LEG CRAMP; NAUSEA; NORMAL HUMAN; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL; TABLET; VERTIGO;

EID: 0033790827     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1300314     Document Type: Article

References (11)

1. Micronized 17b-estradiol for oral estrogen therapy in menopausal women
2. Current concepts in estrogen replacement therapy in the menopause
3. Hip fracture and the use of estrogens in postmenopausal women. The framingham study
4. Long-term estrogen replacement therapy prevents bone loss and fractures
5. Estrogen therapy arrests bone loss in elderly women
6. Clinical and lipid metabolic effects of unopposed oestrogen and two oestrogen-progestogen regimens in post-menopausal women
7. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study
8. Menopausal oestrogen therapy and protection from death from ischaemic heart disease
9. Natural (oestrogen as an effective treatment for type-II hyperlipoproteinaemia in postmenopausal women
10. Estrogen replacement therapy and cognitive function in postmenopausal women without dementia
11. Alzheimer's disease: An estrogen link?